Cite
Targeting Tumor Associated Phosphatidylserine with New Zinc Dipicolylamine-Based Drug Conjugates.
MLA
Yu-Wei Liu, et al. “Targeting Tumor Associated Phosphatidylserine with New Zinc Dipicolylamine-Based Drug Conjugates.” Bioconjugate Chemistry, vol. 28, no. 7, July 2017, pp. 1878–92. EBSCOhost, https://doi.org/10.1021/acs.bioconjchem.7b00225.
APA
Yu-Wei Liu, Kak-Shan Shia, Chien-Huang Wu, Kuan-Liang Liu, Yu-Cheng Yeh, Chen-Fu Lo, Chiung-Tong Chen, Yun-Yu Chen, Teng-Kuang Yeh, Wei-Han Chen, Jiing-Jyh Jan, Yu-Chen Huang, Chen-Lung Huang, Ming-Yu Fang, Gray, B. D., Pak, K. Y., Tsu-An Hsu, Kuan-Hsun Huang, & Tsou, L. K. (2017). Targeting Tumor Associated Phosphatidylserine with New Zinc Dipicolylamine-Based Drug Conjugates. Bioconjugate Chemistry, 28(7), 1878–1892. https://doi.org/10.1021/acs.bioconjchem.7b00225
Chicago
Yu-Wei Liu, Kak-Shan Shia, Chien-Huang Wu, Kuan-Liang Liu, Yu-Cheng Yeh, Chen-Fu Lo, Chiung-Tong Chen, et al. 2017. “Targeting Tumor Associated Phosphatidylserine with New Zinc Dipicolylamine-Based Drug Conjugates.” Bioconjugate Chemistry 28 (7): 1878–92. doi:10.1021/acs.bioconjchem.7b00225.